136 related articles for article (PubMed ID: 17097759)
41. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
[TBL] [Abstract][Full Text] [Related]
42. [Epidermal growth factor receptor and phosphorylated Akt protein expression in non-small-cell lung cancer].
Zhou ZL; Yang F; Jiang GC; Huang YQ; Fu J; Wang J
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1062-5. PubMed ID: 18754442
[TBL] [Abstract][Full Text] [Related]
43. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
Hirsch FR; Varella-Garcia M; McCoy J; West H; Xavier AC; Gumerlock P; Bunn PA; Franklin WA; Crowley J; Gandara DR;
J Clin Oncol; 2005 Oct; 23(28):6838-45. PubMed ID: 15998906
[TBL] [Abstract][Full Text] [Related]
44. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
Xu YH; Lu S
Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
[TBL] [Abstract][Full Text] [Related]
45. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
46. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective.
Paralkar VR; Li T; Langer CJ
Clin Lung Cancer; 2008 Mar; 9(2):116-21. PubMed ID: 18501099
[TBL] [Abstract][Full Text] [Related]
47. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
[TBL] [Abstract][Full Text] [Related]
48. Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Zhang Q; Wang J; Zhang H; Zhao D; Zhang Z; Zhang S
J Cancer Res Ther; 2015; 11(1):223-8. PubMed ID: 25879366
[TBL] [Abstract][Full Text] [Related]
49. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
[TBL] [Abstract][Full Text] [Related]
50. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
[TBL] [Abstract][Full Text] [Related]
51. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study.
Pirker R; Pereira JR; von Pawel J; Krzakowski M; Ramlau R; Park K; de Marinis F; Eberhardt WE; Paz-Ares L; Störkel S; Schumacher KM; von Heydebreck A; Celik I; O'Byrne KJ
Lancet Oncol; 2012 Jan; 13(1):33-42. PubMed ID: 22056021
[TBL] [Abstract][Full Text] [Related]
52. The impact of cigarette smoking on prognosis in small adenocarcinomas of the lung: the association between histologic subtype and smoking status.
Sakao Y; Miyamoto H; Oh S; Takahashi N; Inagaki T; Miyasaka Y; Akaboshi T; Sakuraba M
J Thorac Oncol; 2008 Sep; 3(9):958-62. PubMed ID: 18758296
[TBL] [Abstract][Full Text] [Related]
53. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.
Chen KY; Chen JH; Shih JY; Yang CH; Yu CJ; Yang PC
J Thorac Oncol; 2010 Jan; 5(1):82-9. PubMed ID: 19884854
[TBL] [Abstract][Full Text] [Related]
54. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
[TBL] [Abstract][Full Text] [Related]
55. [Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma].
Wang CL; Yue DS; Zhang ZF; Zhan ZL; Sun LN
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2350-4. PubMed ID: 18036300
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of bronchioloalveolar carcinoma component in lung adenocarcinoma.
Lin DM; Ma Y; Zheng S; Liu XY; Zou SM; Wei WQ
Histol Histopathol; 2006 Jun; 21(6):627-32. PubMed ID: 16528673
[TBL] [Abstract][Full Text] [Related]
57. Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung.
Breathnach OS; Ishibe N; Williams J; Linnoila RI; Caporaso N; Johnson BE
Cancer; 1999 Oct; 86(7):1165-73. PubMed ID: 10506700
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of phospho-Akt in patients with non-small cell lung carcinoma: a meta-analysis.
Yang Y; Luo J; Zhai X; Fu Z; Tang Z; Liu L; Chen M; Zhu Y
Int J Cancer; 2014 Sep; 135(6):1417-24. PubMed ID: 24523200
[TBL] [Abstract][Full Text] [Related]
59. Impact and interactions between smoking and traditional prognostic factors in lung cancer progression.
Guo NL; Tosun K; Horn K
Lung Cancer; 2009 Dec; 66(3):386-92. PubMed ID: 19304339
[TBL] [Abstract][Full Text] [Related]
60. [Expression and prognostic value of AKT2 in non-small cell lung cancer].
Miao X; Song Y; Lv T; Zhan P; Lv Y; Yuan D
Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):396-9. PubMed ID: 21569643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
